The treatment of advanced multiple sclerosis with nicotinic acid and a combination of nicotinic acid and thiamin chloride has yielded promising results in cases in which the patients have failed to respond to therapies hitherto used. While complete remission has not been obtained, the use of the treatment suggested here has resulted in continued symptomatic improvement. The potential value of the suggested treatment may be judged in the light of prevailing conceptions of the etiology and treatment of multiple sclerosis.
From 1838, when Sir Robert Carswell, as cited by Putnam,1 first described the pathology of multiple sclerosis, up to the present, the treatment of this disease has been entirely empiric. When one examines the diversity of remedial agents and methods employed, it becomes evident that the disarray is occasioned by complete ignorance of the etiology of the disease, coupled with the desire to find a remedy for one of the
MOORE MT. TREATMENT OF MULTIPLE SCLEROSIS WITH NICOTINIC ACID AND VITAMIN B1: PRELIMINARY REPORT. Arch Intern Med (Chic). 1940;65(1):1–20. doi:10.1001/archinte.1940.00190070011001
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: